juvenile idiopathic arthritis

Novartis stakes another PhIII win for Cosentyx, goes deeper into pediatric markets
Endpoints
Wed, 06/2/21 - 10:54 am
Novartis
Cosentyx
juvenile idiopathic arthritis
AbbVie's Humira Receives FDA Approval for JIA
Drug Discovery and Development
Tue, 10/7/14 - 07:45 am
AbbVie
Humira
FDA
juvenile idiopathic arthritis